Royalty Pharma Appoints Head of AI

Royalty Pharma plc has announced the appointment of Lucas Glass as its new Head of Artificial Intelligence. This strategic move underscores the company's commitment to leveraging AI in its operations and research. Glass's leadership in AI is expected to drive innovation and enhance the company's capabilities in identifying and developing pharmaceutical assets. The appointment signals a growing focus on integrating advanced technologies within the pharmaceutical investment sector.